TB-500 Testing: Why Mass Matters More Than Purity
TB-500 is a 43-amino-acid peptide, so identity by mass spectrometry is the check that counts. Here is what the HPLC and mass results should show on a Certificate of Analysis.
Month: October 2026
Tesamorelin Research Overview: What Is Known and Unknown
A plain-language look at what published laboratory research has examined about Tesamorelin, a 44-amino-acid GHRH analog, and where the evidence is still thin.
GHK-Cu vs BPC-157: How the Peptides in GLOW Differ
GHK-Cu and BPC-157 differ in size, structure and the pathways researchers study. Here is how they compare, and how to tell them apart on a Certificate of Analysis.
What the Names in BPC Wolverine + KPV Actually Mean
BPC Wolverine + KPV is a nickname plus four abbreviations. Here is what each name refers to, which versions exist, and how to tell what a vial contains.
Incretin Research History Behind BioLean2 Tirz GIP
Where GIP and GLP-1 research began, who identified these gut peptides, and how the science led to the dual-agonist class that BioLean2 Tirz GIP belongs to.
BioLean3 Reta Certificate of Analysis: What to Check
How BioLean3 Reta is verified: identity by mass, purity by HPLC and content per vial, plus what each line of its Certificate of Analysis should show.
What Published NAD+ Research Actually Examines
NAD+ is a coenzyme at the center of cellular energy and repair pathways. Here is what published laboratory research has examined, and what remains unknown.
What Is in a Tesamorelin Ipamorelin 5mg/5mg Blend Vial
A plain profile of our Tesamorelin / Ipamorelin 5mg/5mg blend: what is in the vial, how the two peptides differ in size, what published research examines, and how the blend is tested.
What Is Kisspeptin-10? The Shortest Active Kisspeptin
A plain profile of Kisspeptin-10 (KP-10, Metastin 45-54): what the peptide is, the receptor it targets, what researchers study it for, and how we verify it.